Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jieon Lee, Su-jin Rhee, SeungHwan Lee & Kyung-Sang Yu. (2018) Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians. Drug Design, Development and Therapy 12, pages 787-794.
Read now
Read now
Articles from other publishers (11)
Vasilisa Krivovicheva, Andrey Bubyrev, Stanislav Kalinin, Dmitry Dar'in & Mikhail Krasavin. (2022)
Synthetic Exploration of Novel Sulfamoyl Cyanide
N
‐Oxides in Heterocycle Synthesis
. European Journal of Organic Chemistry 2022:46.
Crossref
Crossref
Ahmed M. Farghaly, Ola H. Rizk, Inas Darwish, Manal Hamza, Mezna Saleh Altowyan, Assem Barakat & Mohamed Teleb. (2022) Design, Synthesis, Pharmacodynamic and In Silico Pharmacokinetic Evaluation of Some Novel Biginelli-Derived Pyrimidines and Fused Pyrimidines as Calcium Channel Blockers. Molecules 27:7, pages 2240.
Crossref
Crossref
Mohsen Safakheil & Hosein Safakheil. (2020) The Effect of Exosomes Derived from Bone Marrow Stem Cells in Combination with Rosuvastatin on Functional Recovery and Neuroprotection in Rats After Ischemic Stroke. Journal of Molecular Neuroscience 70:5, pages 724-737.
Crossref
Crossref
Xiao-Jian Zhang, Wen-Zhong Wang, Rong Zhou, Zhi-Qiang Liu & Yu-Guo Zheng. (2019) Asymmetric synthesis of tert-butyl (3R,5S)-6-chloro-3,5-dihydroxyhexanoate using a self-sufficient biocatalyst based on carbonyl reductase and cofactor co-immobilization. Bioprocess and Biosystems Engineering 43:1, pages 21-31.
Crossref
Crossref
Jianan Geng, Huali Xu, Xiaofeng Yu, Guoliang Xu, Hongyan Cao, Guangzhu Lin & Dayun Sui. (2018) Rosuvastatin protects against oxidized low‑density lipoprotein‑induced endothelial cell injury of atherosclerosis in�vitro. Molecular Medicine Reports.
Crossref
Crossref
Young Hee Lee, Mayavan Viji, Eunhwa Lee, Hyeju Jo, Kyung Yoo, Jaeuk Sim, Sunhwan Lee, Kiho Lee, Heesoon Lee & Jae-Kyung Jung. (2017) Synthesis and characterization of Rosuvastatin calcium impurity A; a HMG-CoA reductase inhibitor. Tetrahedron Letters 58:26, pages 2614-2617.
Crossref
Crossref
S Vidyadhara, RLC Sasidhar, Y.A Chowdary, K.L. Lavanya & S. B Lakshmi. (2016) DESIGN AND EVALUATION OF ROSUVASTATIN SMEDDS FOR ENHANCING SOLUBILITY AND DISSOLUTION RATE. INDIAN DRUGS 53:03, pages 40-46.
Crossref
Crossref
Htar H. Nwe, Jonathan N. Bullman, Shashidhar M. Joshi, Annie Stylianou & Shiva G. Kapsi. (2016) The relative bioavailability of 2 prototype fixed-dose combination formulations for amlodipine and rosuvastatin in healthy white and Chinese subjects. Clinical Pharmacology in Drug Development 5:2, pages 131-140.
Crossref
Crossref
Stefano Tartaggia, Clark Ferrari, Marta Pontini & Ottorino De Lucchi. (2015) A Practical Synthesis of Rosuvastatin and Other Statin Intermediates. European Journal of Organic Chemistry 2015:19, pages 4102-4107.
Crossref
Crossref
Gokhan Kurt, Emre C. Gokce, Berker Cemil, Zuhal Yildirim, Gulnur T. Kaplanoglu, Emre Durdag & Bulent Erdogan. (2015) Neuroprotective Effects of Rosuvastatin in Spinal Cord Ischemia-Reperfusion Injury in Rabbits. Neurosurgery Quarterly 25:2, pages 189-196.
Crossref
Crossref
Mark Spengler, Michael Adler & Christof M. Niemeyer. (2015) Highly sensitive ligand-binding assays in pre-clinical and clinical applications: immuno-PCR and other emerging techniques. The Analyst 140:18, pages 6175-6194.
Crossref
Crossref